Management of overactive bladder review: the role of percutaneous tibial nerve stimulation

  • Elita Wibisono Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta
  • Harrina E. Rahardjo Department of Urology, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta
DOI: https://doi.org/10.13181/mji.v25i4.1385
Keywords: electrical stimulation overactive bladder, percutaneous tibial nerve stimulation
Abstract viewed: 2035 times
PDF downloaded: 1239 times
HTML downloaded: 734 times
EPUB downloaded: 107 times

Abstract

Overactive bladder (OAB) is a common condition that is experienced by around 455 million people (11% of the world population) and associated with significant impact in patients' quality of life. The first line treatments of OAB are conservative treatment and anti-muscarinic medication. For the refractory OAB patients, the treatment options available are surgical therapy, electrical stimulation, and botulinum toxin injection. Among them, percutaneous tibial nerve stimulation (PTNS) is a minimally invasive option that aims to stimulate sacral nerve plexus, a group of nerve that is responsible for regulation of bladder function. After its approval by food and drug administration (FDA) in 2007, PTNS revealed considerable promise in OAB management. In this review, several non-comparative and comparative studies comparing PTNS with sham procedure, anti-muscarinic therapy, and multimodal therapy combining PTNS and anti-muscarinic had supportive data to this consideration.

References

  1. Payne CK. Conservative Management of Urinary Incontinence: Behavioral and Pelvic Floor Therapy, Urethral and Pelvic Devices. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 1. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 2026–46. https://doi.org/10.1016/B978-1-4160-6911-9.00069-4

  2. Staskin D, Kelleher C, Bosch R, Cotterill N, Coyne K, Kopp Z, et al. Initial assessment of urinary incontinence in adult male and female patients. In: Abrams P, Cardozo L, Khoury S, Wein A, editors. Incontinence: 5th International Consultation on Incontinence. France: ICUD-EAU; 2013. p. 361–88.

  3. Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P, et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourology and urodynamics. 2009;28(4):287. https://doi.org/10.1002/nau.20737

  4. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourology and urodynamics. 2002;21(2):167–78. https://doi.org/10.1002/nau.10052

  5. Sumardi R, Mochtar CA, Junizaf, Santoso BI, Setiati S, Nuhonni SA, et al. Prevalence of urinary incontinence, risk factors and its impact: multivariate analysis from indonesian nationwide survey. Acta medica Indonesiana. 2014;46(3):175–82.

  6. Percutaneous tibial nerve stimulation for the treatment of overactive bladder [Internet]. California Technology Assessment Forum. 2012 [cited June 20, 2012]. Available from: http://ctaf.org/sites/default/files/assessments/PTNS June 2012_0.pdf.

  7. Drake M, Abrams P. Overactive bladder. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 1. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 1947–56. https://doi.org/10.1016/B978-1-4160-6911-9.00066-9

  8. Banakhar MA, Al-Shaiji TF, Hassouna MM. Pathophysiology of overactive bladder. International urogynecology journal. 2012;23(8):975–82. https://doi.org/10.1007/s00192-012-1682-6

  9. Steers WD. Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol. 2002;4(Suppl 4):S7-18.

  10. Vasavada SP, Rackley RR. Electrical stimulation and neuromodulation in storage and emptying failure. In: Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 1. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 2026–45. https://doi.org/10.1016/B978-1-4160-6911-9.00070-0

  11. Chu FM, Dmochowski R. Pathophysiology of overactive bladder. The American journal of medicine. 2006;119(3):3–8. https://doi.org/10.1016/j.amjmed.2005.12.010

  12. Abrams P, Andersson K, Birder L, Brubaker L, Cardozo L, Chapple C, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourology and urodynamics. 2010;29(1):213–40. https://doi.org/10.1002/nau.20870

  13. Chapple C, Khullar V, Gabriel Z, Dooley JA. The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. European urology. 2005;48(1):5–26. https://doi.org/10.1016/j.eururo.2005.02.024

  14. Gopal M, Haynes K, Bellamy SL, Arya LA. Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstetrics & Gynecology. 2008;112(6):1311–8. https://doi.org/10.1097/AOG.0b013e31818e8aa4

  15. Sexton CC, Notte SM, Maroulis C, Dmochowski RR, Cardozo L, Subramanian D, et al. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. International journal of clinical practice. 2011;65(5):567–85. https://doi.org/10.1111/j.1742-1241.2010.02626.x

  16. Brostrom S, Hallas J. Persistence of antimuscarinic drug use. European journal of clinical pharmacology. 2009;65(3):309–14. https://doi.org/10.1007/s00228-008-0600-9

  17. Tanagho EA, Bella AJ, Lue TF. Neuropathic bladder disorders. In: Tanagho EA, McAninch JW, editors. Smith's general urology. 17th ed. New York: McGraw-Hill Medical; 2008. p. 438–54.

  18. Herbison GP, Arnold EP. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. The Cochrane Library. 2009. https://doi.org/10.1002/14651858.cd004202.pub2

  19. Burton C, Sajja A, Latthe P. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta-analysis. Neurourology and urodynamics. 2012;31(8):1206–16. https://doi.org/10.1002/nau.22251

  20. Gungor Ugurlucan F, Onal M, Aslan E, Ayyildiz Erkan H, Kizilkaya Beji N, Yalcin O. Comparison of the effects of electrical stimulation and posterior tibial nerve stimulation in the treatment of overactive bladder syndrome. Gynecologic and obstetric investigation. 2013;75(1):46â52. https://doi.org/10.1159/000343756

  21. Govier FE, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. The Journal of urology. 2001;165(4):1193–8. https://doi.org/10.1016/S0022-5347(05)66469-5

  22. van der Pal F, Heesakkers JP, Bemelmans BL. Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction. Current opinion in urology. 2006;16(4):261–7. https://doi.org/10.1097/01.mou.0000232047.87803.1e

  23. Chen Y-F, Bramley G, Unwin G, Dretzke J, Moore D, Hanu-Cernat D. Systematic Reviews referred by the NICE Interventional Procedures Programme on behalf of the NICE Interventional Procedures Advisory Committee (IPAC) Title Stimulation of peripheral nerves for the treatment of refractory pain (including peripheral nerve field. 2012.

  24. Lucas M, Bedretdinova D, Bosch J, Burkhard F, Cruz F, Nambiar A, et al. EAU guidelines of urinary incontinence. 2013.

  25. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. The Journal of urology. 2012;188(6):2455–63. https://doi.org/10.1016/j.juro.2012.09.079

  26. MacDiarmid SA, Staskin DR. Percutaneous tibial nerve stimulation (PTNS): a literature-based assessment. Current Bladder Dysfunction Reports. 2009;4(1):29–33. https://doi.org/10.1007/s11884-009-0005-3

  27. Van Balken M, Vergunst H, Bemelmans B. Prognostic factors for successful percutaneous tibial nerve stimulation. European urology. 2006;49(2):360–5. https://doi.org/10.1016/j.eururo.2005.10.019

  28. Nuhoğlu B, Fidan V, Ayyıldız A, Ersoy E, Germiyanoğlu C. Stoller afferent nerve stimulation in woman with therapy resistant over active bladder; a 1-year follow up. International urogynecology journal. 2006;17(3):204–7. https://doi.org/10.1007/s00192-005-1370-x

  29. Van Der Pal F, Van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU international. 2006;97(3):547–50. https://doi.org/10.1111/j.1464-410X.2006.06055.x

  30. Finazzi Agro E, Campagna A, Sciobica F, Petta F, Germani S, Zuccala A, et al. Posterior tibial nerve stimulation: is the once-a-week protocol the best option? Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2005;57(2):119–23.

  31. Karademir K, Baykal K, Sen B, Senkul T, Iseri C, Erden D. A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation. Scandinavian journal of urology and nephrology. 2005;39(3):230–3. https://doi.org/10.1080/00365590510031147

  32. Finazzi Agro E, al. e. Percutaneous tibial nerve stimulation (PTNS) in the treatment of urge incontinence: A double blind placebo controlled study. SIUD National Congress; Italy: Uroplasty; 2005.

  33. Finazzi Agro E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. The Journal of urology. 2010;184(5):2001–6. https://doi.org/10.1016/j.juro.2010.06.113

  34. Finazzi Agro E, Rocchi C, Pachatz C, Petta F, Spera E, Mori F, et al. Percutaneous tibial nerve stimulation produces effects on brain activity: study on the modifications of the long latency somatosensory evoked potentials. Neurourology and urodynamics. 2009;28(4):320–4. https://doi.org/10.1002/nau.20651

  35. Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. The Journal of urology. 2010;183(4):1438–43. https://doi.org/10.1016/j.juro.2009.12.036

  36. Wibisono E, Rahardjo HE. Effectiveness of short term percutaneous tibial nerve stimulation for non-neurogenic overactive bladder syndrome in adults: a systematic review and meta analysis. Acta Med Indones. 2015;47(3):188-200.

  37. Souto SC, Reis LO, Palma T, Palma P, Denardi F. Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome. World journal of urology. 2014;32(1):179–84. https://doi.org/10.1007/s00345-013-1112-5

  38. Peters KM, MacDiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. The Journal of urology. 2009;182(3):1055–61. https://doi.org/10.1016/j.juro.2009.05.045

  39. Vecchioli-Scaldazza C, Morosetti C, Berouz A, Giannubilo W, Ferrara V. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study. Gynecologic and obstetric investigation. 2012;75(4):230–4. https://doi.org/10.1159/000350216

  40. Sancaktar M, Ceyhan ST, Akyol I, Muhcu M, Alanbay I, Mutlu Ercan C, et al. The outcome of adding peripheral neuromodulation (stoller afferent neuro-stimulation) to anti-muscarinic therapy in women with severe overactive bladder. Gynecological Endocrinology. 2010;26(10):729–32. https://doi.org/10.3109/09513591003649815

  41. Kabay SC, Kabay S, Yucel M, Ozden H. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourology and urodynamics. 2009;28(1):62–7. https://doi.org/10.1002/nau.20593

  42. Gobbi C, Digesu G, Khullar V, El Neil S, Caccia G, Zecca C. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Multiple Sclerosis Journal. 2011;17(12):1514–9. https://doi.org/10.1177/1352458511414040

  43. De Gennaro M, Capitanucci M, Mastracci P, Silveri M, Gatti C, Mosiello G. Percutaneous tibial nerve neuromodulation is well tolerated in children and effective for treating refractory vesical dysfunction. The Journal of urology. 2004;171(5):1911–3. https://doi.org/10.1097/01.ju.0000119961.58222.86

  44. Hoebeke P, Renson C, Petillon L, Walle JV, De Paepe H. Percutaneous electrical nerve stimulation in children with therapy resistant nonneuropathic bladder sphincter dysfunction: a pilot study. The Journal of urology. 2002;168(6):2605–8. https://doi.org/10.1016/S0022-5347(05)64227-9

  45. MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. The Journal of urology. 2010;183(1):234–40. https://doi.org/10.1016/j.juro.2009.08.160

  46. Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, et al. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study. Neurourology and urodynamics. 2013;32(1):24–9. https://doi.org/10.1002/nau.22266

  47. Peters K, Carrico D, editors. Percutaneous tibial nerve stimulation for the treatment of overactive bladder syndrome: final 36-month results of the STEP study. Neurology and Urodynamics; 2013: Wiley-Blackwell.

Published
2017-01-25
How to Cite
1.
Wibisono E, Rahardjo HE. Management of overactive bladder review: the role of percutaneous tibial nerve stimulation. Med J Indones [Internet]. 2017Jan.25 [cited 2024Apr.20];25(4):245-54. Available from: http://mji.ui.ac.id/journal/index.php/mji/article/view/1385
Issue
Vol. 25 No. 4 (2016): December
Section
Review Article

Copyright (c) 2017 Elita Wibisono, Harrina E. Rahardjo

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with Medical Journal of Indonesia agree to the following terms:

  1. Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
  2. Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.